SAMSUNG BIOLOGICS financial statements, including revenue, expenses, profit, and loss

The total revenue of 207940 for the last quarter is 946.90 B KRW, and it's 11.79% lower compared to the previous quarter. The net income of Q1 24 is 179.36 B KRW.